These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
292 related articles for article (PubMed ID: 29086229)
1. The yield of targeted genotyping for the recurring mutations in BRCA1/2 in Israel. Bernstein-Molho R; Laitman Y; Schayek H; Reish O; Lotan S; Haim S; Zidan J; Friedman E Breast Cancer Res Treat; 2018 Feb; 167(3):697-702. PubMed ID: 29086229 [TBL] [Abstract][Full Text] [Related]
2. The yield of full BRCA1/2 genotyping in Israeli high-risk breast/ovarian cancer patients who do not carry the predominant mutations. Barnes-Kedar I; Bernstein-Molho R; Ginzach N; Hartmajer S; Shapira T; Magal N; Kalis ML; Peretz T; Shohat M; Basel-Salmon L; Friedman E; Bazak L; Goldberg Y Breast Cancer Res Treat; 2018 Nov; 172(1):151-157. PubMed ID: 30014164 [TBL] [Abstract][Full Text] [Related]
3. Yield of targeted genotyping for the recurring pathogenic variants in cancer susceptibility genes in a healthy, multiethnic Israeli population. Bernstein-Molho R; Galmor L; Laitman Y; Segev S; Friedman E Cancer; 2021 Oct; 127(19):3599-3604. PubMed ID: 34157778 [TBL] [Abstract][Full Text] [Related]
4. Ovarian cancer risk in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations. Satagopan JM; Boyd J; Kauff ND; Robson M; Scheuer L; Narod S; Offit K Clin Cancer Res; 2002 Dec; 8(12):3776-81. PubMed ID: 12473589 [TBL] [Abstract][Full Text] [Related]
5. Germline mutations in BRCA1 and BRCA2 genes in ethnically diverse high risk families in Israel. Laitman Y; Borsthein RT; Stoppa-Lyonnet D; Dagan E; Castera L; Goislard M; Gershoni-Baruch R; Goldberg H; Kaufman B; Ben-Baruch N; Zidan J; Maray T; Soussan-Gutman L; Friedman E Breast Cancer Res Treat; 2011 Jun; 127(2):489-95. PubMed ID: 20960228 [TBL] [Abstract][Full Text] [Related]
6. Targeted genotyping for recurring variants in cancer susceptibility genes in non-Ashkenazi Jewish patients with breast cancer diagnosed ≥50 years. Bernstein-Molho R; Shhada NA; Laitman Y; Netzer I; Shoval S; Friedman E Cancer; 2024 Aug; 130(16):2763-2769. PubMed ID: 38630906 [TBL] [Abstract][Full Text] [Related]
7. The yield of full BRCA1/2 genotyping in Israeli Arab high-risk breast/ovarian cancer patients. Bernstein-Molho R; Barnes-Kedar I; Ludman MD; Reznik G; Feldman HB; Samra NN; Eilat A; Peretz T; Peretz LP; Shapira T; Magal N; Kalis ML; Yerushalmi R; Vinkler C; Liberman S; Basel-Salmon L; Shohat M; Levy-Lahad E; Friedman E; Bazak L; Goldberg Y Breast Cancer Res Treat; 2019 Nov; 178(1):231-237. PubMed ID: 31368036 [TBL] [Abstract][Full Text] [Related]
8. The 1100delAT BRCA1 and the 8765delAG BRCA2 mutations: occurrence in high-risk non-Ashkenazi Jews and haplotype comparison of Jewish and non-Jewish carriers. Gal I; Gershoni Baruch R; Haber D; Dagan E; Eisenberg-Barzilai S; Zidan J; Friedman E Fam Cancer; 2004; 3(1):11-4. PubMed ID: 15131400 [TBL] [Abstract][Full Text] [Related]
9. Cancer risk in Jewish BRCA1 and BRCA2 mutation carriers: effects of oral contraceptive use and parental origin of mutation. Bernholtz S; Laitman Y; Kaufman B; Paluch Shimon S; Friedman E Breast Cancer Res Treat; 2011 Sep; 129(2):557-63. PubMed ID: 21499684 [TBL] [Abstract][Full Text] [Related]
10. Genetic counseling in hereditary breast/ovarian cancer in Israel: psychosocial impact and retention of genetic information. DiCastro M; Frydman M; Friedman I; Shiri-Sverdlov R; Papa MZ; Goldman B; Friedman E Am J Med Genet; 2002 Aug; 111(2):147-51. PubMed ID: 12210341 [TBL] [Abstract][Full Text] [Related]
11. Incidence of BRCA1 and BRCA2 non-founder mutations in patients of Ashkenazi Jewish ancestry. Rosenthal E; Moyes K; Arnell C; Evans B; Wenstrup RJ Breast Cancer Res Treat; 2015 Jan; 149(1):223-7. PubMed ID: 25476495 [TBL] [Abstract][Full Text] [Related]
12. BRCA1 and BRCA2 mutations in males with familial breast and ovarian cancer syndrome. Results of a Spanish multicenter study. de Juan I; Palanca S; Domenech A; Feliubadaló L; Segura Á; Osorio A; Chirivella I; de la Hoya M; Sánchez AB; Infante M; Tena I; Díez O; Garcia-Casado Z; Vega A; Teulé À; Barroso A; Pérez P; Durán M; Carrasco E; Juan-Fita MJ; Murria R; Llop M; Barragan E; Izquierdo Á; Benítez J; Caldés T; Salas D; Bolufer P Fam Cancer; 2015 Dec; 14(4):505-13. PubMed ID: 26026974 [TBL] [Abstract][Full Text] [Related]
13. Inherited predisposition to breast and ovarian cancer in non-Jewish populations in Israel. Zidan J; Zhou AY; van den Akker J; Laitman Y; Schayek H; Schnaider J; Friedman E Breast Cancer Res Treat; 2017 Dec; 166(3):881-885. PubMed ID: 28828701 [TBL] [Abstract][Full Text] [Related]
14. BRCA1/2 germline mutations in Jewish patients with uterine serous carcinoma. Bruchim I; Amichay K; Kidron D; Attias Z; Biron-Shental T; Drucker L; Friedman E; Werner H; Fishman A Int J Gynecol Cancer; 2010 Oct; 20(7):1148-53. PubMed ID: 21206239 [TBL] [Abstract][Full Text] [Related]
15. [GENOTYPE-PHENOTYPE CORRELATIONS BY SPECIFIC FOUNDER VARIANTS IN BRCA IN ISRAELI WOMEN]. Michaelson-Cohen R; Laitman Y; Kedar I; Baris-Feldman H; Reish O; Lieberman S; Bernstein-Molho R; Goldberg Y; Reznick Levi G; Gershoni R; Beller U; Levy-Lahad E; Catan R; Friedman E Harefuah; 2023 Jun; 162(6):370-375. PubMed ID: 37394440 [TBL] [Abstract][Full Text] [Related]
16. Phenocopy breast cancer rates in Israeli BRCA1 BRCA2 mutation carrier families: is the risk increased in non-carriers? Bernholtz S; Laitman Y; Kaufman B; Shimon-Paluch S; Friedman E Breast Cancer Res Treat; 2012 Apr; 132(2):669-73. PubMed ID: 22113258 [TBL] [Abstract][Full Text] [Related]
17. BRCA1 and BRCA2 germline mutations screening in Algerian breast/ovarian cancer families. Cherbal F; Bakour R; Adane S; Boualga K; Benais-Pont G; Maillet P Dis Markers; 2010; 28(6):377-84. PubMed ID: 20683152 [TBL] [Abstract][Full Text] [Related]
18. Statewide Retrospective Review of Familial Pancreatic Cancer in Delaware, and Frequency of Genetic Mutations in Pancreatic Cancer Kindreds. Catts ZA; Baig MK; Milewski B; Keywan C; Guarino M; Petrelli N Ann Surg Oncol; 2016 May; 23(5):1729-35. PubMed ID: 26727920 [TBL] [Abstract][Full Text] [Related]
19. Comprehensive genetic characterization of hereditary breast/ovarian cancer families from Slovakia. Konecny M; Milly M; Zavodna K; Weismanova E; Gregorova J; Mlkva I; Ilencikova D; Kausitz J; Bartosova Z Breast Cancer Res Treat; 2011 Feb; 126(1):119-30. PubMed ID: 21203900 [TBL] [Abstract][Full Text] [Related]
20. Increased prevalence of the founder BRCA1 c.5309G>T and recurrent BRCA2 c.1310_1313delAAGA mutations in breast cancer families from Northerstern region of Morocco: evidence of geographical specificity and high relevance for genetic counseling. Melki R; Melloul M; Aissaoui S; El Harroudi T; Boukhatem N BMC Cancer; 2023 Apr; 23(1):339. PubMed ID: 37055759 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]